Effects of midazolam on acute phase of stroke in two patients with mitochondrial encephalopathy, lactic acidosis and stroke-like episodes

No To Hattatsu

Volumn 35, Issue 1, 2003, Pages 71-74

  Ohtsu, M ^a   Nakano, K ^a   Maeda, Y ^a   Muto, A ^a   Tsurumi, E ^a   Yazaki, E ^a   Katsumori, H ^a   Hayashi, K ^a   Osawa, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ADRENOMEDULLIN; DIAZEPAM; ENDOTHELIN 1; LIDOCAINE; MIDAZOLAM; PHENYTOIN;

ARTICLE; BRAIN DISEASE; CASE REPORT; CHILD; CYTOPATHOGENIC EFFECT; HUMAN; LACTIC ACIDOSIS; MALE; MELAS SYNDROME; MITOCHONDRION; NUCLEAR MAGNETIC RESONANCE IMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE;

EID: 0037278982     PISSN: 00290831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Sakuta R, Nonaka I. Vascular involvement in mitochondrial myopathy. Ann Neurol 1989; 25: 594-601.
2. Ohama E, Ohara S, Ikuta F, Tanaka K, Nishizawa M, Miyatake T. Mitochondrial angiopathy in the cerebral blood vessels of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes). No To Shinkei 1988; 40: 109-18.
3. Oldendorf WH, Cornford ME, Brown WJ. The large apparent work capability of the blood-brain barrier: a study of the mitochondrial content of capillary endthelial cells in brain and other tissues of the rat. Ann Neurol 1977; 5: 409-17.
4. Gropen TI, Prohovnik I, Tatemichi TK, Hirano M. Cerebral hyperemia in MELAS. Stroke 1994: 25: 1873-6.
5. Yoneda M, Maeda M, Kimura H, Fujii A, Katayama K, Kuriyama M. Vasogenic edema on MELAS: a serial study with diffusion-weighted MR imaging. Neurology 1999; 53: 2182-4.
6. Sano M. Ishii K, Momose Y, Uchigata M, Senda M. Cerebral metabolism of oxygen and glucose in patient with MELAS syndrome. Acta Neurol Scand 1995; 92: 497-502.
7. Mukoyama M, Kazui H, Sunahara N, Yoshida M, Nonaka I, Satoyoshi E. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes with acanthocytosis: a clinicopathological study of unique case. J Neurol 1986; 233: 228-32.
8. Funakawa I, Yasuda A, Terao A. Periodic lateralized epileptiform discharges in mitochondrial encephalomyopathy. Electroencephalogr Clin Neurophysiol 1997; 103: 370-5.
9. Tulinius MH, Hagne I. EEG findings in children and adolescents with mitochondrial encephalomyopathies: a study of 25 cases. Brain Dev 1991; 13: 167-73.
10. Fujimoto S, Mizuno K, Shibata H, et al. Serial electroencephalographic findings in patients with MELAS. Pediatr Neurol 1999; 20: 43-8.
11. Canafoglia L, Franceschetti S, Antozzi C, et al. Epileptic phenotypes associated with mitochondrial disorders. Neurology 2001; 56: 1340-6.
12. Blumer JL. Clinical pharmacology of midazolam in infants and children. Clin Pharmacokinet 1998; 35: 34-47.
13. Hayashi Y, Minamino N, Isumi Y, Kangawa K, Kuro M, Matsuo H. Effects of thiopental, ketamine, etomidate, propofol and midazolam on the production of adrenomedulline and endothelin-1 in vascular smooth muscle cells. Res Commun Mol Pathol Pharmachol 1999; 103: 325-31.
14. Koga Y, Ishibashi M, Ueki I, et al. Effects of L-arginine on the acute phase of strokes in three patients with MELAS. Neurology 2002; 58: 827-8.